---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-215168"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2024-09-06T23:59:59+00:00"
generated_at: "2026-05-31T06:02:36.797364+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jazz Prices $1B 3.125% Exchangeable Notes Due 2030, Preps $500M Loan Repayment & $150M Buyback

## Summary
- $1.0B aggregate principal of 3.125% exchangeable senior notes due 2030, including $150M overallotment exercised.
- Initial exchange price ~$153.05 per share, a ~40% premium over Sept 3 closing price of $109.32.
- Net proceeds ~$981M; ~$500M to prepay term loans under credit agreement, remainder for general corporate.
- Concurrent $150M share repurchase from note purchasers at $109.32/share, reducing remaining buyback authority.
- Transaction closed Sept 6, 2024; notes guaranteed by Jazz on senior unsecured basis.

## SEC filing metadata
- accession: 0001193125-24-215168
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2024-09-06T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312524215168/0001193125-24-215168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312524215168/d875709d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-215168
- JSON: https://secwatch.observer/filing/0001193125-24-215168.json
- Plain text: https://secwatch.observer/filing/0001193125-24-215168.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.